Arnold J. Levine - 12 May 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Director
Signature
/s/ Winston Kung, by power of attorney
Issuer symbol
PMVP
Transactions as of
12 May 2021
Net transactions value
-$122,929
Form type
4
Filing time
22 Jul 2021, 16:28:00 UTC
Next filing
21 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Sale $122,929 -3,500 -0.83% $35.12 416,842 20 Jul 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Award $0 +5,781 $0.000000 5,781 12 May 2021 Common Stock 5,781 $28.33 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.54 to $35.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Shares subject to the option vest in 36 equal monthly installments beginning on June 12, 2021.